Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
‘Shocking’ inflation numbers will fall back to earth and hurt reopening trades, economist David Rosenberg predicts – CNBC
Article feature image
U.S. stock futures are flat with the S&P 500 at a record high – CNBC
Article feature image
7-Eleven Day is canceled again. But you can still get a free Slurpee this July – CNN